Search Results - "GIORDANO ATTIANESE, Greta Maria Paola"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Coengineering specificity, safety, and function into T cells for cancer immunotherapy by Giordano Attianese, Greta Maria Paola, Ash, Sarah, Irving, Melita

    Published in Immunological reviews (01-11-2023)
    “…Adoptive T-cell transfer (ACT) therapies, including of tumor infiltrating lymphocytes (TILs) and T cells gene-modified to express either a T cell receptor…”
    Get full text
    Journal Article
  2. 2

    Hemicentin 1 influences podocyte dynamic changes in glomerular diseases by Toffoli, Barbara, Zennaro, Cristina, Winkler, Carine, Giordano Attianese, Greta Maria Paola, Bernardi, Stella, Carraro, Michele, Gilardi, Federica, Desvergne, Béatrice

    “…Different complex mechanisms control the morphology of podocyte foot processes and their interactions with the underlying basement membrane. Injuries to this…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5

    CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues by Cribioli, Elisabetta, Giordano Attianese, Greta Maria Paola, Coukos, George, Irving, Melita

    Published in Frontiers in immunology (05-08-2022)
    “…Chimeric antigen receptor (CAR) T cells have emerged as a powerful immunotherapeutic tool against certain hematological malignancies but a significant…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Chimeric T-cell receptors: new challenges for targeted immunotherapy in hematologic malignancies by Biagi, Ettore, Marin, Virna, Giordano Attianese, Greta Maria Paola, Dander, Erica, D'Amico, Giovanna, Biondi, Andrea

    Published in Haematologica (Roma) (01-03-2007)
    “…"Centro di Ricerca Matilde Tettamanti", Department of Paediatrics, University of Milano-Bicocca, San Gerardo Hospital, Monza, Milan, Italy. Correspondence:…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Targeting of Acute Myeloid Leukemia by Cytokine-Induced Killer Cells Redirected with a Novel CD123-Specific Chimeric Antigen Receptor by Tettamanti, Sarah, Marin, Virna, Pizzitola, Irene, Magnani, Chiara Francesca, Attianese, Greta Maria Paola Giordano, Cribioli, Elisabetta, Lopez, Angel, Biondi, Andrea, Bonnet, Dominique, Biagi, Ettore

    Published in Blood (16-11-2012)
    “…Abstract 3010 Current therapeutic regimens for Acute Myeloid Leukemia (AML) are still associated with high rates of relapse. In the last years, great interest…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Generation of a New Chimeric Antigen Receptor (CAR) to Target CD23 Expressed on Chronic Lymphocytic Leukemia (B-CLL) Cells by Attianese, Greta Maria Paola Giordano, Hoyos, Valentina, Savoldo, Barbara, Marin, Virna, Brandi, Malika, Biondi, Andrea, Biagi, Ettore, Dotti, Gianpietro

    Published in Blood (16-11-2008)
    “…B-Chronic lymphocytic leukemia (B-CLL) is characterized by a progressive accumulation of mature B-lymphocytes expressing CD19, CD20dim and aberrantly…”
    Get full text
    Journal Article
  19. 19

    New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future by Biagi, Ettore, Marin, Virna, Attianese, Greta Maria Paola Giordano, Pizzitola, Irene, Tettamanti, Sarah, Cribioli, Elisabetta, Biondi, Andrea

    Published in Italian journal of pediatrics (22-09-2011)
    “…Leukaemia immunotherapy represents a fascinating and promising field of translational research, particularly as an integrative approach of bone marrow…”
    Get full text
    Journal Article